Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variants

Aishun Jin(Chongqing Medical University), Ailong Huang(Chongqing Medical University), Haitao Yang(Fujian Medical University), Jingjing Huang(Chongqing Medical University), Guiji Zhang(Chongqing Medical University), Tingting Li(Tianjin University), Yingyi Long(Chongqing Medical University), Song Mu, Shunhua Long(Chongqing Medical University), Kai Wang(Xinjiang Medical University), Xiaojian Han(Chongqing Medical University), Shuyi Song(Chongqing Medical University), Feiyang Luo(Zhujiang Hospital), Yang Wu(Liverpool School of Tropical Medicine), Xiaoyun Ji(Southwest Jiaotong University), Jie Hu(Fudan University), Meiying Shen, Ni Tang(Ho Chi Minh City University of Education), Zhenghong Yuan(Shanghai Medical College of Fudan University), Hangtian Guo(Nanjing University), Wei Wang(Chongqing Medical University), Jianwei Wang(Zhejiang Cancer Hospital), Qian Chen(Suzhou Research Institute), Youhua Xie(Shanghai Medical College of Fudan University), Yingming Wang(China Pharmaceutical University), Li Luo(Third People's Hospital of Chengdu), Wang Wang(South-West University "Neofit Rilski"), Chenjian Gu(Washington University in St. Louis), Xia Cai(Fudan University), Yanan Hao(North China University of Science and Technology), Changlong He(Army Medical University), Wei Xu(Shanghai Medical College of Fudan University), Fengxia Gao(Chongqing Medical University), Chao Hu(Second Affiliated Hospital of Nanjing Medical University), Qingzhu Gao(MRC Laboratory of Molecular Biology), Di Qu(Xijing Hospital), Shenglong Li(Dalian University of Technology), Rui‐Xin Wu(Air Force Medical University), Fengjiang Liu(Guangzhou Experimental Station)
Research Square
February 12, 2021
Cited by 0


Related Papers